Praxis-Studien
   
 

 

 

 

    ../images/log2.gif  
AUO Nr.: AN 43/17 Niere   Details zur Studie         
Titel: A NATIONAL, PROSPECTIVE, NON-INTERVENTIONAL STUDY (NIS) OF NIVOLUMAB (BMS-936558) IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA AFTER PRIOR THERAPY
Studienleiter: Herr Dr. Martin Herber - Bristol-Myers-Squibb GmbH & Co. KGaA  80636 München Arnulfstr. 29 Tel:089/12 142-217